Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STARS I: Esomeprazole in Functional Dyspepsia
NCT00251914Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Dec 2002
- Primary completion
- Jan 2005
- Modality
- Small Molecules
- Countries
- 17
01
Overview
Phase 3, randomised, double-blind trial in functional dyspepsia (FD) comparing Esomeprazole with Placebo (2 arms). Primary endpoints: Responder Status after 8 weeks, Daily Symptom Score and 1 more. Started Dec 2002; status: completed.
02
Drugs
esomeprazole
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT00251914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00251914.